UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma

Oncoimmunology, 2020-01, Vol.9 (1), p.1846915-1846915

2020

Volltextzugriff (PDF)

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

Nature communications, 2017-11, Vol.8 (1), p.1447-10, Article 1447

2017

Volltextzugriff (PDF)

Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy

The Journal of clinical investigation, 2018-11, Vol.128 (11), p.5137-5149

2018

Volltextzugriff (PDF)

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity

Cancer immunology research, 2017-08, Vol.5 (8), p.676-684

2017

Volltextzugriff (PDF)

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway

Clinical cancer research, 2018-03, Vol.24 (5), p.1138-1151

2018

Volltextzugriff (PDF)

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Cancer immunology research, 2020-11, Vol.8 (11), p.1365-1380

2020

Volltextzugriff (PDF)

Despite KLRG1 expression, highly cytotoxic ThEO/TcEO polarized T cells efficiently establish immunologic memory

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.133-133.39

2016

Volltextzugriff (PDF)

Mechanisms underlying 4-1BB agonist antibody mediated hepatotoxicity

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.188-188.5

2016

Volltextzugriff (PDF)

Abstract PR02: Melanoma evolves complete immunotherapy resistance through acquisition of a hypermetabolic phenotype

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.PR02-PR02

2020

Volltextzugriff (PDF)

Abstract 1700: Metabolic adaptations confer immunotherapy resistance in melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1700-1700

2018

Volltextzugriff (PDF)

Abstract 629: Combination hypoxia-specific chemotherapy and immunotherapy of prostate cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.629-629

2014

Volltextzugriff (PDF)

Abstract A21: Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27 dependent pathway

Cancer immunology research, 2018-09, Vol.6 (9_Supplement), p.A21-A21

2018

Volltextzugriff (PDF)

Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma

Cancer immunology research, 2018-09, Vol.6 (9_Supplement), p.PR08-PR08

2018

Volltextzugriff (PDF)

Neuroprotective Factors Secreted by U‐87 Astrocytoma (Astrocytes‐Like) Cells and Their Associated Metabolic Adaptation

The FASEB journal, 2010-04, Vol.24 (S1), p.763.6-763.6

2010

Volltextzugriff (PDF)

Tumor hypoxia drives immune suppression and immunotherapy resistance

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P392-P392, Article P392

2015

Volltextzugriff (PDF)

Toxicity of Silicon Dioxide Nanoparticles in Mammalian Neural Cells

Handbook of Clinical Nanomedicine, 2016, p.985-1012

2016

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(15)
Buchkapitel
(1)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(7)
Life Sciences & Biomedicine
(6)
Animals
(4)
Lymphocytes
(4)
Melanoma
(4)
Mice
(4)
Oncology
(4)
Cancer
(3)
Cd8-Positive T-Lymphocytes - Immunology
(3)
Cell Line, Tumor
(3)
Ctla-4 Antigen - Antagonists & Inhibitors
(3)
Ctla-4 Protein
(3)
Immune Checkpoint
(3)
Immunology
(3)
Immunotherapy
(3)
Lymphocytes T
(3)
Mice, Knockout
(3)
Pd-1 Protein
(3)
Tumors
(3)
Cd8 Antigen
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity

Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Despite KLRG1 expression, highly cytotoxic ThEO/TcEO polarized T cells efficiently establish immunologic memory

Mechanisms underlying 4-1BB agonist antibody mediated hepatotoxicity

Abstract PR02: Melanoma evolves complete immunotherapy resistance through acquisition of a hypermetabolic phenotype

Abstract 1700: Metabolic adaptations confer immunotherapy resistance in melanoma

Abstract 629: Combination hypoxia-specific chemotherapy and immunotherapy of prostate cancer

Abstract A21: Activation of 4-1BB on liver myeloid cells triggers hepatitis via an interleukin-27 dependent pathway

Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma

Neuroprotective Factors Secreted by U‐87 Astrocytoma (Astrocytes‐Like) Cells and Their Associated Metabolic Adaptation

Tumor hypoxia drives immune suppression and immunotherapy resistance

Toxicity of Silicon Dioxide Nanoparticles in Mammalian Neural Cells

Suchergebnisse filtern